Breaking News
Get 45% Off 0
⚖ What's the current risk profile of the stocks in my watchlist? (Yes, you can ask that.)
Chat with WarrenAI
Close

Perpetuum Vita Spezial R (0P00001CPR)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
39.350 +0.070    +0.18%
05/06 - Closed. Currency in EUR
Type:  Fund
Market:  Luxembourg
ISIN:  LU0225963817 
Asset Class:  Equity
  • Morningstar Rating:
  • Total Assets: 6.13M
Perpetuum Vita Spezial R 39.350 +0.070 +0.18%

0P00001CPR Holdings

 
Comprehensive information about top holdings and Key Holding Information for the Perpetuum Vita Spezial R (0P00001CPR) fund. Our Perpetuum Vita Spezial R portfolio information includes stock holdings, annual turnover, top 10 holdings, sector and asset allocation.

Asset Allocation

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Name  Net %  Long %  Short %
Cash 10.370 10.580 0.210
Shares 79.430 80.130 0.700
Bonds 10.060 10.060 0.000
Convertible 0.130 0.130 0.000

 Style Box

Value & Growth Measures

Ratios Value Category Average
P/E Ratio 14.012 16.189
Price to Book 1.817 2.414
Price to Sales 1.238 1.814
Price to Cash Flow 5.661 9.832
Dividend Yield 3.637 2.492
5 Years Earnings Growth 8.815 10.650

Sector Allocation

Name  Net % Category Average
Financial Services 18.680 16.458
Industrials 17.870 12.372
Consumer Defensive 12.290 7.487
Utilities 11.480 3.209
Healthcare 8.510 11.865
Technology 7.190 18.923
Energy 6.240 4.882
Basic Materials 6.230 7.059
Consumer Cyclical 4.740 11.886
Communication Services 4.330 7.533
Real Estate 2.450 2.794

Region Allocation

  • North America
  • Europe Developed
  • Asia
  • Developed Markets

Top Holdings

Number of long holdings: 51

Number of short holdings: 2

Name ISIN Weight % Last Change %
  Deutsche Telekom AG DE0005557508 3.41 33.980 +0.89%
IP Blue X LU1626623844 3.33 - -
European Union EU000A3L6N78 3.31 - -
Nordrhein-Westfalen (Land) DE000NRW0MP9 3.25 - -
  Allianz DE0008404005 3.25 353.90 +0.28%
  Siemens AG DE0007236101 3.23 219.25 +0.55%
  European Union 3 04-Mar-2053 EU000A3K4DY4 3.12 86.500 -0.33%
ALPORA Sustainable Technologies Y LU2270686715 3.01 - -
  Iberdrola ES0144580Y14 2.85 15.970 +0.28%
  Sanofi FR0000120578 2.84 87.49 +0.42%

Top Equity Funds by Fund Development and Advisory AG

  Name Rating Total Assets YTD% 3Y% 10Y%
  FCP MEDICAL BioHealth-Trends EUR 574.88M -13.22 5.80 6.34
  FCP MEDICAL BioHealth Trends I 574.88M -13.07 6.33 7.23
  FCP MEDICAL BioHealth Trends I H 574.88M -5.34 6.24 5.55
  FCP MEDICAL BioHealth Trends EUR H 574.88M -6.17 5.77 4.71
  FFPB MultiTrend Plus 223.77M -0.71 2.64 1.44
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P00001CPR Comments

Write your thoughts about Perpetuum Vita Spezial R
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email